glp 1 for people who are not obese GLP-1 Agonists Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Frontiers | GLP−1 receptor agonists

This means that, in addition to lowering glucose [blood sugar] and weight, they modulate inflammation, cardiovascular physiology, gastric emptying, and potentially tumor biology, Cuomo explained

This protective mechanism helps safeguard our cells, tissues, and organs from premature aging and disease

GLP-1 initiators had higher rates of metformin use (32.7% vs

Jacobsen DW, Gatautis VJ, Green R, Robinson K, Savon SR, Secic M et al (1994)

Lancet 372(9645):12401250 Drucker DJ, Sherman SI, Gorelick FS, Bergenstal RM, Sherwin RS, Buse JB (2010) Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits